Verastem VSTM
NASDAQ VSTM
$8.20 +0.22 (+2.82%)
As of: Sep 4, 2026 · 3:59 PM EDT

Verastem (VSTM) Cash & Current Investments (2011 - 2026)

Verastem (VSTM) posted quarterly Cash & Current Investments of $197.8 million for Q1 2026, up 68.26% year-over-year from $117.6 million in Q1 2025, and down 3.49% quarter-over-quarter from $205.0 million in Q4 2025.

Analysis

Verastem (VSTM) Cash & Current Investments (2011 - 2026) Analysis & Trends

Verastem's Cash & Current Investments history runs 16 years deep, the most recent figure standing at $197.8 million for Q1 2026.

  • In Q1 2026, Cash & Current Investments rose 68.26% year-over-year to $197.8 million; the TTM figure through Mar 2026 stood at $197.8 million (up 68.26% YoY), while the FY2025 annual figure was $205.0 million, up 130.8% from the prior year.
  • Cash & Current Investments for Q1 2026 stood at $197.8 million, down from $205.0 million in the prior quarter.
  • The five-year high for Cash & Current Investments was $205.0 million in Q4 2025, with the low at $83.4 million in Q2 2024.
  • The 5-year median for Cash & Current Investments is $113.2 million (2024), against an average of $130.1 million.
  • The sharpest annual moves came in 2024 and 2025: Cash & Current Investments sank 54.46% in 2024, then jumped 130.8% in 2025.
  • Verastem's Cash & Current Investments stood at $92.0 million in 2022, then surged by 48.99% to $137.1 million in 2023, then sank by 35.23% to $88.8 million in 2024, then surged by 130.8% to $205.0 million in 2025, then declined by 3.49% to $197.8 million in 2026.
  • Business Quant data shows VSTM's Cash & Current Investments at $197.8 million in Q1 2026, $205.0 million in Q4 2025, and $137.7 million in Q3 2025.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Cash & Current Investments (Qtr)
1 Vertex Pharmaceuticals 138.47 Bn 130.62 Bn 2.84 Bn 7.85 Bn
2 Regeneron Pharmaceuticals 85.18 Bn 77.19 Bn 3.93 Bn 7.99 Bn
3 Argenx Se 63.38 Bn 58.19 Bn 1.37 Bn 5.18 Bn
4 Moderna 58.09 Bn 52.95 Bn 52.00 Mn 5.14 Bn
5 Revolution Medicines 44.33 Bn 44.33 Bn - -
6 BeOne Medicines 40.02 Bn 34.92 Bn 1.53 Bn 5.10 Bn
7 Alnylam Pharmaceuticals 35.57 Bn 32.27 Bn 992.69 Mn 3.31 Bn
8 Royalty Pharma 28.45 Bn 27.61 Bn - 836.99 Mn
9 Insmed 27.48 Bn 26.32 Bn 358.27 Mn 1.16 Bn
10 Verastem 814.94 Mn 678.59 Mn 36.32 Mn 136.35 Mn
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 136.35 Mn
Mar 31, 2026 197.83 Mn
Dec 31, 2025 204.99 Mn
Sep 30, 2025 137.71 Mn
Jun 30, 2025 164.32 Mn
Mar 31, 2025 117.57 Mn
Dec 31, 2024 88.82 Mn
Sep 30, 2024 113.18 Mn
Jun 30, 2024 83.37 Mn
Mar 31, 2024 110.13 Mn
Dec 31, 2023 137.13 Mn
Sep 30, 2023 165.66 Mn
Jun 30, 2023 183.09 Mn
Mar 31, 2023 111.20 Mn
Dec 31, 2022 87.89 Mn
Sep 30, 2022 103.98 Mn
Jun 30, 2022 94.31 Mn
Mar 31, 2022 106.28 Mn
Dec 31, 2021 100.26 Mn
Sep 30, 2021 103.42 Mn